Oblon Announces Election of a New Partner
Oblon, McClelland, Maier & Neustadt, LLP is pleased to announce the election of a new partner – Robert Tarcu – effective in 2020.
USPTO Issues Second Federal Register Notice on Artificial Intelligence and Innovation
On October 30, 2019, the USPTO issued a second Federal Register Notice requesting comments on artificial intelligence patent issues to assist in "evaluating whether further examination guidance is needed to promote the reliability and predictability of patenting artificial intelligence inventions." The comment period, ending on December 16, 2019, is now open.
USPTO Requests Comments on Artificial Intelligence Patent Issues
On August 27, 2019, the USPTO issued a Federal Register Notice requesting comments on artificial intelligence patent issues to assist in "evaluating whether further examination guidance is needed to promote the reliability and predictability of patenting artificial intelligence inventions."
Oblon Ranked Again in IAM Patent 1000
Oblon's Patent Prosecution practice and partners from the firm's Chemical, Electrical & Mechanical and Litigation practices have received top national rankings in the 2019 edition of IAM Patent 1000: The World's Leading Patent Professionals.
Oblon Files Petition for Certiorari in PTAB Standing Issue in JTEKT vs. GKN Automotive LTD.
Oblon has filed a petition for certiorari after the United States Court of Appeals for the Federal Circuit declined its petition for panel rehearing and rehearing en banc on behalf of its client
IP Strategies for Medical Device Technologies: Be Your Own Incubator Co-Edited by James Love has been Published
"IP Strategies for Medical Device Technologies: Be Your Own Incubator" a book co edited by James Love has been published and is available to purchase here.
4 Ways Advances In AI Could Challenge Patent Law
Sameer Gokhale is quoted in a recent article by Law360 on Artificial Intelligence patent law.